4//SEC Filing
LLOYD RONALD K. 4
Accession 0001104659-21-064573
CIK 0001708527other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:40 PM ET
Size
7.1 KB
Accession
0001104659-21-064573
Insider Transaction Report
Form 4
LLOYD RONALD K.
DirectorPresident and CEO
Transactions
- Purchase
Class A Common Stock
2021-05-07$12.28/sh+1,367$16,787→ 23,151 total - Purchase
Class A Common Stock
2021-05-07$11.65/sh+7,198$83,857→ 21,784 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.20 to $12.18. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001644078
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 4:40 PM ET
- Size
- 7.1 KB